Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 2 days · Every feed →

All 28Congress 1Executive branch 0Insiders 27
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

HALO · Insiders · $250K+ · 27 trades

Trades
27
Buys 0 · Sells 27
People
3
Stocks
1
Disclosed value
$21.3M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$337Kdisclosed Oct 8 · filed the same day
  2. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.2Mdisclosed Oct 8 · filed 1 day after the trade
  3. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.1Mdisclosed Oct 8 · filed 2 days after the trade
  4. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$955Kdisclosed Oct 8 · filed 1 day after the trade
  5. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$520Kdisclosed Oct 8 · filed the same day
  6. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.3Mdisclosed Oct 8 · filed the same day
  7. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$656Kdisclosed Oct 8 · filed 2 days after the trade
  8. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$358Kdisclosed Oct 2 · filed 1 day after the trade
  9. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$961Kdisclosed Sep 17 · filed 1 day after the trade
  10. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$320Kdisclosed Sep 17 · filed 1 day after the trade
  11. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$436Kdisclosed Sep 17 · filed 1 day after the trade
  12. ▼ SELLMatthew L. Posard DirectorHALO Halozyme Therapeutics, Inc.$329Kdisclosed Sep 17 · filed 1 day after the trade
  13. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$485Kdisclosed Sep 11 · filed the same day
  14. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.4Mdisclosed Sep 11 · filed 2 days after the trade
  15. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$582Kdisclosed Sep 11 · filed 1 day after the trade
  16. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.6Mdisclosed Sep 11 · filed 1 day after the trade
  17. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$711Kdisclosed Sep 11 · filed 2 days after the trade
  18. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.7Mdisclosed Sep 11 · filed the same day
  19. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1Mdisclosed Aug 19 · filed the same day
  20. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$923Kdisclosed Aug 19 · filed 2 days after the trade
  21. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$766Kdisclosed Aug 19 · filed the same day
  22. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$986Kdisclosed Aug 19 · filed 1 day after the trade
  23. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$588Kdisclosed Aug 19 · filed 1 day after the trade
  24. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$510Kdisclosed Aug 19 · filed 1 day after the trade
  25. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$776Kdisclosed Aug 19 · filed 2 days after the trade